Cargando…

Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence Are Damaged by In Vitro Exposure to its Dyslipidemic Serum, Predicting Inadequate Repair Capacity In Vivo

Female stress urinary incontinence (FSUI) is prevalent in women with type 2 diabetes/obesity (T2D/O), and treatment is not optimal. Autograph stem cell therapy surprisingly has poor efficacy. In the male rat model of T2D/O, it was demonstrated that epigenetic changes, triggered by long-term exposure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovanecz, Istvan, Gelfand, Robert, Lin, Guiting, Sharifzad, Sheila, Ohanian, Alec, Ricks, Randy, Lue, Tom, Gonzalez-Cadavid, Nestor F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720976/ https://www.ncbi.nlm.nih.gov/pubmed/31430893 http://dx.doi.org/10.3390/ijms20164044

Ejemplares similares

Evaluation of the In Vitro Damage Caused by Lipid Factors on Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence
por: Kovanecz, Istvan, et al.
Publicado: (2020)

Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle
por: Tsao, James, et al.
Publicado: (2013)

Muscle Derived Stem Cells Stimulate Muscle Myofiber Repair and Counteract Fat Infiltration in a Diabetic Mouse Model of Critical Limb Ischemia
por: Tsao, J, et al.
Publicado: (2016)

Treatment of stress urinary incontinence with low-intensity extracorporeal shock wave therapy in a vaginal balloon dilation induced rat model
por: Wu, Alex K., et al.
Publicado: (2018)

Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013)

Urinary Incontinence
por: Feneley, R.C.L., et al.
Publicado: (1982)

Effects of sildenafil and/or muscle derived stem cells on myocardial infarction
por: Wang, Judy SC, et al.
Publicado: (2012)

Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation
por: Tomczyk, Marta, et al.
Publicado: (2021)

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

ORAL BISPHENOL A (BPA) GIVEN TO RATS AT MODERATE DOSES IS ASSOCIATED WITH ERECTILE DYSFUNCTION, CAVERNOSAL LIPOFIBROSIS, AND ALTERATIONS OF GLOBAL GENE TRANSCRIPTION
por: Kovanecz, I, et al.
Publicado: (2013)

Urinary Incontinence: An Update
por: Zivkovic, Dragana, et al.
Publicado: (2019)

Clozapine and urinary incontinence
por: Osca Oliver, A., et al.
Publicado: (2022)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)

Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017)

Potential benefits of L. acidophilus in dyslipidemic rats
por: Reamtong, Onrapak, et al.
Publicado: (2021)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Muscle-Derived Cells for Treatment of Iatrogenic Sphincter Damage and Urinary Incontinence in Men
por: Gerullis, H., et al.
Publicado: (2012)

URINARY INCONTINENCE IN ACUTE PSYCHOSIS
por: Choudhury, S., et al.
Publicado: (1993)

Urodynamic assessment of urinary incontinence
por: Housley, Sarah L., et al.
Publicado: (2010)

Management of male urinary incontinence
por: Moore, Katie C., et al.
Publicado: (2010)

Urinary Incontinence Induced by Tramadol
por: Gautam, Sujeet KS, et al.
Publicado: (2013)

Urinary Incontinence and Physician's Attitude
por: Park, Won Hee
Publicado: (2013)

Treatment of mixed urinary incontinence
por: Gomelsky, Alex, et al.
Publicado: (2011)

The management of childhood urinary incontinence
por: Maternik, Michal, et al.
Publicado: (2014)

Female urinary incontinence and sexuality
por: Mota, Renato Lains
Publicado: (2017)

Clinical Evaluation of Urinary Incontinence
por: Sharma, Nidhi, et al.
Publicado: (2018)

Psychometric properties of the German-language questionnaire for urinary incontinence diagnosis (QUID) in women with urinary incontinence
por: Brandt, Florian, et al.
Publicado: (2021)

The effect of dyslipidemic drugs on mortality: A meta-analysis
por: Jain, Shuchi, et al.
Publicado: (2009)

Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)

Stress Urinary Incontinence Among Young Nulliparous Female Athletes
por: Joseph, Christine, et al.
Publicado: (2021)

Developing Repair Materials for Stress Urinary Incontinence to Withstand Dynamic Distension
por: Hillary, Christopher J., et al.
Publicado: (2016)

Urinary Incontinence in Longstay Mental Patients
por: Kidd, Cecil B., et al.
Publicado: (1959)

Duloxetine in the treatment of stress urinary incontinence
por: Jost, Wolfgang H, et al.
Publicado: (2005)

Cell-Based Therapy for Urinary Incontinence
por: Bae, Jae Hyun, et al.
Publicado: (2010)

Stress urinary incontinence: Sling or colposuspension?
por: Mukha, Rajiv Paul, et al.
Publicado: (2007)

Recent updates in the management of urinary incontinence
por: Badlani, Gopal H.
Publicado: (2007)

Stem Cells for the Treatment of Urinary Incontinence
por: Staack, Andrea, et al.
Publicado: (2010)

Biomaterials in urinary incontinence and treatment of their complications
por: Sangster, Philippa, et al.
Publicado: (2010)

Effects of bariatric surgery on urinary incontinence
por: Bulbuller, Nurullah, et al.
Publicado: (2017)

Evaluation and Management of Male Urinary Incontinence
por: Stone, Anthony R., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5mn5h8nsvvqs7d1b5h7q75grtf